Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Julie-Anne Therese Matheson has a total of 24 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Needs and Expectations for the myNewWay Blended Digital and Face-to-Face Psychotherapy Model of Care for Depression and Anxiety (Part 2): Participatory Design Study including Mental Health Professionals

    by Rosemaree Kathleen Miller, Kathleen O'MOore, Katarina Kikas, Julie-Anne Therese Matheson, Alexis Estelle Whitton, Peter Baldwin, Sophie Li, Melissa Black, Laura Kampel, Nicole Cockayne, et al.

    Background: In blended care, digital mental health interventions (DMHIs) integrate with face-to-face psychotherapy provided in person or via telehealth. To incorporate DMHIs into routine care for depression and anxiety, it is important to understand the needs and expectations of mental health professionals for blended DMHIs. Objective: The study objective was to partner with Australian mental health professionals in the design of a transdiagnostic, cognitive behavioral therapy–based blended model of care for adults experiencing depression and anxiety. Methods: Participants were Australian health professionals who treat adults with depression and anxiety. The participatory design process included a web-based survey (N=258), one-on-one interviews (N=14), and a 2-part focus group (N=6). Quantitative and qualitative data were collected through the web-based survey. In-depth qualitative feedback from interviews and the 2-part focus group was subjected to reflexive thematic analysis. Results: Mental health professionals found blended care with face-to-face therapy more acceptable than telehealth and blended care with telehealth, with standalone DMHIs being the least preferred option. The most common ways in which mental health professionals thought a DMHI could integrate with face-to-face psychotherapy included homework completion (129/178, 72.5%), skills practice to support in-session therapy (128/178, 71.9%), and psychoeducation (127/178, 71.3%). Mental health professionals expect the blended DMHI to be easy to use, flexible, protective of client data, and to include evidence-based content from several therapeutic modalities (eg, cognitive behavioral therapy and mindfulness). Other preferences included mental health professionals being able to prescribe specific program modules to their clients, track the treatment progress of clients, and receive alerts if their clients’ symptoms worsened. In terms of implementation, mental health professionals were concerned about the time and effort needed to use blended care. They suggested that ongoing training and support would help mental health professionals implement blended care with their clients. Monitoring client risk and progress via a web-based dashboard and downloadable summaries was also important. Conclusions: Designing DMHIs that support psychotherapy for adults with depression and anxiety has the potential to increase access to evidence-based treatment. Involving mental health professionals in DMHI design is expected to increase their acceptance of DMHIs and facilitate the integration of these digital products into routine care.


  • Open Access

    Needs and Expectations for the myNewWay Blended Digital and Face-to-Face Psychotherapy Model of Care for Depression and Anxiety (Part 1): Participatory Design Study including People with Lived and Living Experience

    by Katarina Kikas, Kathleen O'MOore, Rosemaree Kathleen Miller, Julie-Anne Therese Matheson, Sophie Li, Kathleen Varghese, Peter Baldwin, Nicole Cockayne, Alexis Estelle Whitton, Jill Maree Newby

    Background: Digital mental health interventions (DMHIs) are effective in reducing symptoms of depression and anxiety. Low user engagement and uptake of DMHIs observed in previous research may be addressed by involving the intended target audience in the design of the DMHI from the outset. Objective: This study is phase 1 of a multiphase project aimed at designing, developing, and evaluating a blended DMHI for depression and anxiety in Australia. Our objective was to partner with adults with lived and living experiences of depression and anxiety on their needs and expectations of a new transdiagnostic DMHI for depression and anxiety. This included identifying strategies that would help increase their engagement with the DMHI and their preferences for integrating the DMHI with psychotherapy. Methods: A mixed methods participatory design approach was used to collect quantitative and qualitative data via a web-based survey (n=324) and semistructured interviews (n=21). Feedback was collected on participants’ needs and expectations for the DMHI, including accessibility, content, features, functionality, format, data sharing, preferred clinical support pathways, and barriers to and facilitators of user engagement. Qualitative interview data were analyzed using reflexive thematic analysis. Results: Most participants (190/257, 73.9%) preferred a DMHI delivered as a smartphone app that could be used at any time of the day. Ease of use and a well-designed interface were important, as was a positive, encouraging, and uplifting DMHI look and feel. Other preferences included symptom tracking, diverse therapeutic content, and features that facilitated social connection and peer support (eg, online community and stories of lived and living experience). Participants also suggested several strategies to enhance engagement with the DMHI, including personalization, reminders, short and achievable activities, and goal setting. Participants reported a strong interest in sharing information from their DMHI with mental health professionals (to facilitate therapy), especially regarding changes to their emotions. Conclusions: Transdiagnostic DMHIs for depression and anxiety have great potential to improve access to affordable, evidence-based mental health support. Involving people with lived and living experiences of depression and anxiety in the design, development, and conceptualization of DMHIs may improve uptake, acceptance, engagement, usability, and ultimately, treatment outcomes.


  • Open Access

    Needs and expectations for the myNewWayTM blended digital and face-to-face psychotherapy model of care for depression and anxiety (Part 2): Mental health professional co-design study (Preprint)

    by Rosemaree Kathleen Miller, Kathleen O'Moore, Katarina Kikas, Julie-Anne Therese Matheson, Alexis Estelle Whitton, Peter Baldwin, Sophie Li, Melissa Black, Laura Kampel, Nicole Cockayne, et al.

    BACKGROUND In blended care, digital mental health interventions (DMHIs) integrate with face-to-face psychotherapy provided in person or via telehealth. To incorporate DMHIs into routine care for depression and anxiety, it is important to understand the needs and expectations of mental health professionals for blended DMHIs. OBJECTIVE The study objective was to partner with Australian mental health professionals in the design of a transdiagnostic, cognitive behavioral therapy-based blended model of care for adults experiencing depression and anxiety. METHODS Participants were Australian health professionals who treat adults with depression and/or anxiety. The co-design process included an online survey (n =258), one-on-one interviews (n=14) and a two-part focus group (n=6). Quantitative and qualitative data were collected through the online survey. In-depth qualitative feedback from interviews and the two-part focus group were subjected to reflexive thematic analysis. RESULTS Mental health professionals found blended care with face-to-face therapy more acceptable than telehealth and blended care with telehealth, with standalone DMHIs being the least preferred option. The most common ways in which mental health professionals thought a DMHI could integrate with face-to-face psychotherapy included homework completion, psychoeducation and skills practice to support in-session therapy. Mental health professionals expect the blended DMHI to be easy to use, flexible, protective of client data and include evidence-based content from several therapeutic modalities (e.g., CBT, mindfulness). Other preferences included mental health professionals being able to prescribe specific program modules to their clients, track the treatment progress of clients and receive alerts if their clients' symptoms worsened. In terms of implementation, mental health professionals were concerned about the effort and time needed to use blended care. They suggested ongoing training and support would help mental health professionals implement blended care with their clients. Monitoring client risk and progress via an online dashboard and downloadable summaries was also important. CONCLUSIONS Designing DMHIs that support psychotherapy for adults with depression and anxiety has the potential to increase access to evidence-based treatment. Involving mental health professionals in DMHI design is expected to increase their acceptance of DMHIs and facilitate the integration of these digital products into routine care.


  • Open Access

    Needs and Expectations for the myNewWay Blended Digital and Face-to-Face Psychotherapy Model of Care for Depression and Anxiety (Part 1): Participatory Design Study including People with Lived and Living Experience (Preprint)

    by Katarina Kikas, Kathleen O'Moore, Rosemaree Kathleen Miller, Julie-Anne Therese Matheson, Sophie Li, Kathleen Varghese, Peter Baldwin, Nicole Cockayne, Alexis Estelle Whitton, Jill Maree Newby

    BACKGROUND Digital mental health interventions (DMHIs) are effective in reducing symptoms of depression and anxiety. Low user engagement and uptake of DMHIs observed in previous research may be addressed by involving the intended target audience in the design of the DMHI from the outset. OBJECTIVE This study is phase 1 of a multiphase project aimed at designing, developing, and evaluating a blended DMHI for depression and anxiety in Australia. Our objective was to partner with adults with lived and living experiences of depression and anxiety on their needs and expectations of a new transdiagnostic DMHI for depression and anxiety. This included identifying strategies that would help increase their engagement with the DMHI and their preferences for integrating the DMHI with psychotherapy. METHODS A mixed methods participatory design approach was used to collect quantitative and qualitative data via a web-based survey (n=324) and semistructured interviews (n=21). Feedback was collected on participants’ needs and expectations for the DMHI, including accessibility, content, features, functionality, format, data sharing, preferred clinical support pathways, and barriers to and facilitators of user engagement. Qualitative interview data were analyzed using reflexive thematic analysis. RESULTS Most participants (190/257, 73.9%) preferred a DMHI delivered as a smartphone app that could be used at any time of the day. Ease of use and a well-designed interface were important, as was a positive, encouraging, and uplifting DMHI look and feel. Other preferences included symptom tracking, diverse therapeutic content, and features that facilitated social connection and peer support (eg, online community and stories of lived and living experience). Participants also suggested several strategies to enhance engagement with the DMHI, including personalization, reminders, short and achievable activities, and goal setting. Participants reported a strong interest in sharing information from their DMHI with mental health professionals (to facilitate therapy), especially regarding changes to their emotions. CONCLUSIONS Transdiagnostic DMHIs for depression and anxiety have great potential to improve access to affordable, evidence-based mental health support. Involving people with lived and living experiences of depression and anxiety in the design, development, and conceptualization of DMHIs may improve uptake, acceptance, engagement, usability, and ultimately, treatment outcomes.

  • Open Access

    The Role of Fecal Microbiota Transplantation in the Treatment of Neurodegenerative Diseases: A Review

    by Julie-Anne T. Matheson, R. M. Damian Holsinger

    Neurodegenerative diseases are highly prevalent but poorly understood, and with few treatment options despite decades of intense research, attention has recently shifted toward other mediators of neurological disease that may present future targets for therapeutic research. One such mediator is the gut microbiome, which communicates with the brain through the gut–brain axis and has been implicated in various neurological disorders. Alterations in the gut microbiome have been associated with numerous neurological and other diseases, and restoration of the dysbiotic gut has been shown to improve disease conditions. One method of restoring a dysbiotic gut is via fecal microbiota transplantation (FMT), recolonizing the “diseased” gut with normal microbiome. Fecal microbiota transplantation is a treatment method traditionally used for Clostridium difficile infections, but it has recently been used in neurodegenerative disease research as a potential treatment method. This review aims to present a summary of neurodegenerative research that has used FMT, whether as a treatment or to investigate how the microbiome influences pathogenesis.


  • Cochlear homeostasis: a molecular physiological perspective on maintenance of sound transduction and auditory neurotransmission with noise and ageing

    by Gary D Housley, Georg von Jonquieres, Jeremy L Pinyon, Julie-Anne T Matheson, Lily J Pearson, Theresa P Salthouse, Jennie Me Cederholm